Hans J.M. Smit

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types

Patrick Sulem, Simon Stacey, Frank Geller et al. · Nature Genetics · 2009 · 613 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975

Egbert F. Smit, J.P.A.M van Meerbeeck, P. Lianes et al. · Journal of Clinical Oncology · 2003 · 352 citations

Medicine, Oncology, Pharmacology +13

Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study

Nicolas Girard, Jair Bar, Pilar Garrido et al. · Journal of Thoracic Oncology · 2022 · 226 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Prevention of Chemotherapy-Induced Febrile Neutropenia by Prophylactic Antibiotics Plus or Minus Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: A Dutch Randomized Phase III Study

Johanna N.H. Timmer-Bonte, Theo M. de Boo, Hans J.M. Smit et al. · Journal of Clinical Oncology · 2005 · 185 citations

Medicine, Oncology, Pharmacology +14

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer

Egbert F. Smit, Sjaak A. Burgers, Bonne Biesma et al. · Journal of Clinical Oncology · 2009 · 154 citations · Full text

Medicine, Oncology, Pharmacotherapy +16